“Staying safe” – a narrative review of falls prevention in people with Parkinson’s – “PDSAFE”
Dementia ResearcherParkinson’s disease demonstrates a spectrum of motor and non-motor symptoms. Falling is common and disabling.
Science
3 hot topics from the world’s largest dementia research conference
Aoife Kiely, Research Communications Officer, shares her highlights from the AAIC with insights from Dr Doug Brown, Chief Policy and Research Officer.
Across Time and Space: Machine Learning Reveals Paths to Dementia
Alz ForumDeveloping computational algorithms & machine-learning techniques, to transform cross-sectional imaging data to a longitudinal picture and reconstruct the sequence of disease progression.
An Antimicrobial Approach to Treating Alzheimer’s?
Brush, Floss, Take a Protease Inhibitor? Do periodontal bacteria cause some cases of Alzheimer’s disease? Scientists at one start-up think so.
An introduction to overviews of reviews: planning a relevant research question and objective for an overview
Overviews of systematic reviews are a relatively new approach to synthesising evidence, and research methods and associated guidance are developing.
Analysing the market for care homes for older people using Care Quality Commission and other data
In this webinar Professor Ruth Hancock analyses the market for care homes for older people using Care Quality Commission and other data.
Are Tauopathies Caused by Neuronal and Glial Senescence?
In AD, tau tangles correlate closely with neurodegeneration, but how they work their mischief remains unclear… or does it?
Bad Synergy—Together, Vascular Problems and Aβ Hasten Memory Slippage
People at risk for future cardiovascular events also face greater odds of developing memory problems, according to a May 23 study in JAMA Neurology.
Brain Conference Spotlights Transcriptomics, Therapeutic Strategies
Around 140 scientists gathered in Rungstedgaard, north of Copenhagen, Denmark, May 5–9 for the biannual Brain Conference organised by the Federation of European Neuroscience Societies and the Lundbeck Foundation. This article from the Alz Forum shares news from the event.
Bump in the Road or Disaster? BACE Inhibitors Worsen Cognition
Merck shook the field with news that people on verubecestat scored worse than those on placebo – find out more in this post from AlzForum
Can Kelp Help Treat AD? Chinese Regulators Think So
GV-971, aka oligomannate, receives conditional approval in China for the treatment of mild to moderate Alzheimer’s disease.